Since I’m not an attorney and I don’t play one on this blog, I’ll let you decide how the guidance below might apply to your situation, whether as the person submitting an application for an exemption ...
On September 1, the Food and Drug Administration issued draft guidance for post-warning letter meeting requests under the Generic Drug User Fee Amendments. Our FDA Compliance & Enforcement Team ...
In December 2019, the Division of Corporation Finance (Staff) of the U.S. Securities and Exchange Commission issued new "CF Disclosure Guidance: Topic No. 7" (Guidance) regarding confidential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results